Related Experiment Video
Updated: Sep 6, 2025

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
Neural-Network-Based Immune Optimization Regulation Using Adaptive Dynamic Programming
Abstract:
This article investigates optimal regulation scheme between tumor and immune cells based on the adaptive dynamic programming (ADP) approach. The therapeutic goal is to inhibit the growth of tumor cells to allowable injury degree and maximize the number of immune cells in the meantime. The reliable controller is derived through the ADP approach to make the number of cells achieve the specific ideal states. First, the main objective is to weaken the negative effect caused by chemotherapy and immunotherapy, which means that the minimal dose of chemotherapeutic and immunotherapeutic drugs can be operational in the treatment process. Second, according to the nonlinear dynamical mathematical model of tumor cells, chemotherapy and immunotherapeutic drugs can act as powerful regulatory measures, which is a closed-loop control behavior. Finally, states of the system and critic weight errors are proved to be ultimately uniformly bounded with the appropriate optimization control strategy and the simulation results are shown to demonstrate the effectiveness of the cybernetics methodology.
Insights
This study uses adaptive dynamic programming to optimize cancer treatment, balancing tumor cell reduction with immune cell enhancement for minimal drug dosage and improved patient outcomes.
Area of Science:
- Computational Biology and Bioinformatics
- Control Theory and Systems Engineering
- Immunology and Cancer Research
Background:
- Cancer treatment faces challenges in balancing tumor suppression with preserving immune function.
- Chemotherapy and immunotherapy can have significant negative side effects.
- Optimal control strategies are needed to minimize drug toxicity while maximizing therapeutic efficacy.
Purpose of the Study:
- To develop an optimal regulation scheme for tumor-immune cell dynamics.
- To inhibit tumor growth to a tolerable level while simultaneously maximizing immune cell populations.
- To minimize the required doses of chemotherapeutic and immunotherapeutic drugs.
Main Methods:
- Utilized the adaptive dynamic programming (ADP) approach for controller design.
- Employed a nonlinear dynamical mathematical model of tumor cell interactions.
- Implemented a closed-loop control strategy for drug administration.
Main Results:
- Derived a reliable controller using ADP to achieve desired cell population states.
- Demonstrated that the control strategy can weaken negative effects of chemotherapy and immunotherapy.
- Proved system states and critic weight errors are ultimately uniformly bounded.
Conclusions:
- The adaptive dynamic programming approach provides an effective cybernetic methodology for cancer treatment optimization.
- This strategy enables precise regulation of tumor and immune cells, leading to potentially improved therapeutic outcomes.
- Simulation results validate the effectiveness of the proposed control strategy in managing cancer dynamics.
Related Concept Videos
Neural Regulation
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cell-mediated Immune Responses
What is the Immune System?

